Description

The rapid pathogen detection market in USA is set to increase by US$ 178.3 million from 2022 to 2028, representing a compound annual growth rate (CAGR) of 6.8% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for rapid pathogen detection. The USA rapid pathogen detection market is segmented on the basis of product, and testing method. On the basis of product, the rapid pathogen detection market in USA has been segmented into detection devices, sensors. The detection devices segment is estimated to account for the largest share of the rapid pathogen detection market in USA. By testing method, the rapid pathogen detection market in USA has been segmented into immunological analysis, mass spectrometry, polymerase chain reaction (PCR). The immunological analysis segment held the largest revenue share in 2021.

The detection device market is further segmented into handheld, installed, portable, and tabletop. The handheld segment held the largest share of the USA rapid pathogen detection market in 2021 and is anticipated to hold its share during the forecast period.

The USA rapid pathogen detection market is highly competitive. Top players covered in USA Rapid Pathogen Detection Market Study are ANP Technologies Inc., Battelle, Bavarian Nordic A/S, BioMerieux S.A., Bruker Detection Corp, Corgenix Medical Corp., Electronic Sensor Technology Inc., Emergent BioSolutions Inc., Eurofins Scientific, GlaxoSmithKline plc (GSK), InBios International Inc., Inovio Pharmaceuticals Inc., LGC Biosearch Technologies, Merck KGaA, Novavax Inc., Soligenix Inc., Thermo Fisher Scientific Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the rapid pathogen detection market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: detection devices, sensors
Testing method: immunological analysis, mass spectrometry, polymerase chain reaction (PCR)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the USA rapid pathogen detection market
– Identify regional strategies and strategic priorities on the basis of local data
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Rapid pathogen detection market overview
Part 3. Market breakdown by product
– Detection devices
– Sensors
Part 4. Market breakdown by testing method
– Immunological analysis
– Mass spectrometry
– Polymerase chain reaction (PCR)
Part 5. Key companies
– ANP Technologies, Inc.
– Battelle
– Bavarian Nordic A/S
– BioMerieux, S.A.
– Bruker Detection Corp
– Corgenix Medical Corp.
– Electronic Sensor Technology, Inc.
– Emergent BioSolutions Inc.
– Eurofins Scientific
– GlaxoSmithKline plc (GSK)
– InBios International, Inc.
– Inovio Pharmaceuticals, Inc.
– LGC Biosearch Technologies
– Merck KGaA
– Novavax, Inc.
– Soligenix, Inc.
– Thermo Fisher Scientific Inc.
About StrategyHelix
Disclaimer